Skip to content
Research Article Open access CC BY 4.0

Cancer-Related Lymphedema: Clinical and Epidemiological Features in Mexico

Luis López-Montoya, Yucari L. Cabanillas, Joceline S. Aguirre, K. Gabriela Saenz-Ramirez, Maria T. Zarate-Sánchez, Angel D. Lopez

Cardiology and Angiology: An International Journal · pp. 152–161 · Published 30 Jun 2022

10.9734/ca/2022/v11i430218

Abstract

Backgroundː There is a lack of clinical and epidemiological knowledge about cancer-related lymphedema in Mexico. The objective of this study is to present a broad and deep report of cancer-related lymphedema’s clinical characteristics and epidemiological features based on the analysis of CRL patients’ data, collected from a specialized rehabilitation clinic in Mexico. Methodsː This is a cohort study based on the analysis of clinical data gathered between 2015 and 2022. The study was developed in a private clinic that specializes in oncological patients’ rehabilitation. Clinical assessments and interviews were performed to collect each case’s clinical history, considering diverse clinical characteristics and demographic information, classified in a matrix, and statistically evaluated. Resultsː Among 307 lymphedema patients, gender distribution was represented by 87.9% (270) female and 12.1% (37) male; mean age of 54.5 years (± 32.5); 79.8% of the patients corresponded to breast cancer diagnosis, the rest of them were associated with other 19 different types of cancer. 90.2% of patients underwent some lymph node removal procedure, 68.1% of patients received fractioned radiotherapy sessions, and 87.7% received some chemotherapy scheme treatment. 64% of patients had a diagnosis of lymphedema and had onset symptoms of lymphedema in the first 5 years after oncological interventions and/or cancer diagnosis, most of them during the first 2 years. The general distribution of clinical staging was: 23.7% in stage 0; 20.1% in stage I; 44.6% in stage II, and in stage III 11.4%. Regarding body mass index, it was found a mean of 26.7 BMI. 61.2% of patients ranged between overweight and obesity. 43.3% of patients with CRL reported a disability to perform one or more activities due to lymphedema. 80% of patients had no physical activity or performed under the minimal physical activity recommended for the population group they belong. Conclusionː This study reports broad epidemiological and clinical features of a group of cancer-related lymphedema patients in Mexico, it was possible to identify diverse potential factors and relations that influence the clinical features of CRL; it is necessary to explore all factors and the interactions among them for a better understanding of CRL patients in the country.

lymphedema secondary lymphedema cancer-related lymphedema lymphedema in Mexico

References (23)

  1. 1 Suspending OpenMP Tasks on Asynchronous Events: Extending the Taskwait Construct [DOI]
  2. 2 Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable [DOI]
  3. 3 Dupilumab for the Treatment of Recalcitrant Bullous Pemphigoid Picosecond Laser Treatment for Acquired Bilateral Nevus of Ota – like Macules [DOI]
  4. 4 THE DIAGNOSIS AND TREATMENT OF PERIPHERAL LYMPHEDEMA: 2020 CONSENSUS DOCUMENT OF THE INTERNATIONAL SOCIETY OF LYMPHOLOGY [DOI]
  5. 5 Long‐Term Effects of Breast Cancer Surgery, Treatment, and Survivor Care [DOI]
  6. 6 Lymphedema and Obesity [DOI]
  7. 7 Persistent Post-Mastectomy Pain: Risk Factors and Current Approaches to Treatment [DOI]
  8. 8 Lymphedema: From diagnosis to treatment [DOI]
  9. 9 Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer [DOI]
  10. 10 Effect of Home-Based Exercise and Weight Loss Programs on Breast Cancer–Related Lymphedema Outcomes Among Overweight Breast Cancer Survivors [DOI]
  11. 11 Psychosocial Issues Associated with Breast Cancer-Related Lymphedema: a Literature Review [DOI]
  12. 12 Worldwide assessment of healthcare personnel dealing with lymphoedema [DOI]
  13. 13 Patient Perceptions of Barriers to Self-Management of Breast Cancer–Related Lymphedema [DOI]
  14. 14 GOG 244 - The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function [DOI]
  15. 15 Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema.
  16. 16 Epidemiology and Morbidity of Lymphedema [DOI]
  17. 17 The women in steady exercise research (WISER) survivor trial: The innovative transdisciplinary design of a randomized controlled trial of exercise and weight-loss interventions among breast cancer survivors with lymphedema [DOI]
  18. 18 Healthcare Practitioners’ Knowledge of Lymphedema [DOI]
  19. 19 Consenso Mexicano sobre diagnóstico y tratamiento del cáncer mamario. Octava revisión. Colima 2019 [DOI]
  20. 20 Development and Feasibility of a Very Low-cost, Home-made, Near Infrared lymphatic Imaging Device [DOI]
  21. 21 Lymphedema in Mexico: A Clinical and Epidemiological Overview [DOI]
  22. 22 Lymphatic Injury and Peripheral Lymphedema as Complications of Central Venous Catheter: A Case Report and a Literature Review [DOI]
  23. 23 El linfedema explicado. Tercera edición. [DOI]

Cited by 1

Trends in physical activity research for breast cancer - A bibliometric analysis of the past ten years

B. Patiño-Palma, Luis López-Montoya, R. Escamilla-Ugarte · Heliyon · 2023

Related research

Article metrics

Real usage data collected on this platform.

66

Page views

0

PDF downloads

27

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.